Stock Price
15.48
Daily Change
-4.15%
Yearly
75.91%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Chugai Pharma 3,733.00 20.00 0.54% -35.09%
Daiichi Sankyo 2,677.50 62.00 2.37% -26.94%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Alnylam Pharmaceuticals 148.50 0.50 0.34% -10.74%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
BioCryst Pharmaceuticals 15.48 -0.67 -4.15% 75.91%
ChemoCentryx 32.50 -0.81 -2.43% -47.60%
DBV Technologies 1.64 -0.01 -0.61% -71.02%
Enanta Pharmaceuticals 60.00 -1.98 -3.19% 28.42%
Gilead Sciences 71.77 -0.11 -0.15% 13.33%
GlaxoSmithKline 1,707.80 66.80 4.07% 21.99%
Glaxosmithkline 45.47 0.41 0.91% 18.20%
Incyte Corp 74.88 1.23 1.67% -17.31%
Ionis Pharmaceuticals 33.08 0.95 2.96% -46.02%
Intra Cellular Therapies 43.07 2.10 5.13% 27.50%
Karyopharm Therapeutics 8.04 0.01 0.12% -46.18%
Mirati Therapeutics 124.31 5.57 4.69% -42.04%
Neurocrine Biosciences 78.36 -0.86 -1.09% -27.24%
Novavax 110.82 -1.56 -1.39% -13.03%
PTC Therapeutics 43.75 1.52 3.60% -36.12%
Ultragenyx Pharmaceutical 72.05 2.16 3.09% -47.78%
Regeneron Pharmaceuticals 615.24 -0.87 -0.14% 18.79%
Roche Holding 367.35 2.35 0.64% 16.64%
Sarepta Therapeutics 71.10 -1.29 -1.78% -21.28%
Vertex Pharmaceuticals 234.06 7.48 3.30% 3.77%
Zogenix 15.93 0.53 3.44% -14.54%

Indexes Price Day Year
NASDAQ 14894 86.94 0.59% 14.58%
US2000 2162 3.02 0.14% 1.85%

BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. discovers oral and small-molecule medicines that treat rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema attacks in adults and pediatric patients 12 years and older. The Company has several ongoing development programs, including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an activin receptor-like kinase-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, an antiviral drug for Marburg virus disease and Yellow Fever. RAPIVAB (peramivir injection) is a viral neuraminidase inhibitor for the treatment of influenza, has received regulatory approval in the United States, Canada, Australia, Japan, Taiwan and Korea.